Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

SRR659484

GTEX

0f1b26bb-029d-525b-9060-16283b45e0c7

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Female

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • PROTEIN_SECRETION+0.242
  • SPERMATOGENESIS+0.237
  • HEME_METABOLISM+0.139
  • HEDGEHOG_SIGNALING+0.114
  • FATTY_ACID_METABOLISM+0.093
  • UV_RESPONSE_DN+0.088
  • OXIDATIVE_PHOSPHORYLATION+0.030
  • BILE_ACID_METABOLISM+0.015
  • PEROXISOME+0.007
  • MITOTIC_SPINDLE-0.007

Top 10 suppressed

  • ANGIOGENESIS-0.451
  • ALLOGRAFT_REJECTION-0.410
  • INFLAMMATORY_RESPONSE-0.404
  • NOTCH_SIGNALING-0.395
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.384
  • TNFA_SIGNALING_VIA_NFKB-0.358
  • IL6_JAK_STAT3_SIGNALING-0.357
  • APOPTOSIS-0.331
  • CHOLESTEROL_HOMEOSTASIS-0.324
  • APICAL_SURFACE-0.316

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR655649
brain-umap@2
GTEX0.954
2SRR11296802
colon-landscapes@1
0.914
3SRR661973
brain-umap@2
GTEX0.899
4SRR659555
brain-umap@2
GTEX0.891
5SRR655218
brain-umap@2
GTEX0.890
6SRR657754
brain-umap@2
GTEX0.881
7SRR658129
brain-umap@2
GTEX0.871
8SRR656745
brain-umap@2
GTEX0.861
9MDT-AP-3207
medullo-epn-umap@date-based
MedMedulloblastoma0.861
10TCGA-A7-A13G-01A-11R-A13Q-07
breast-umap@18
D0.859

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 9 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.242Remibrutinib— uncovered
SPERMATOGENESIS0.237Inavolisib— uncovered
HEME_METABOLISM0.139Temsirolimus— uncovered
HEDGEHOG_SIGNALING0.114Inavolisib— uncovered
FATTY_ACID_METABOLISM0.093Inavolisib— uncovered
UV_RESPONSE_DN0.088Inavolisib— uncovered
OXIDATIVE_PHOSPHORYLATION0.030Remibrutinib— uncovered
BILE_ACID_METABOLISM0.015Inavolisib— uncovered
PEROXISOME0.007Idelalisib— uncovered